PolyProx Therapeutics (AgeTech UK) Biomed
Protein homeostasis, targetting protein misfolding. PolyProx Therapeutics is a biotechnology company focused on the discovery and development of a new class of drugs, Polyproxin molecules, to treat cancer and neurodegenerative diseases. Polyproxin molecules are biopharmaceuticals that selectively target disease-causing proteins and use natural cellular pathways to degrade or remove these proteins.
Technology:
AgeTech Companies
Industry:
UK AgeTech 2020
Headquarters:
United Kingdom
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Register and Claim Ownership